Kabra Drugs, 524322, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

63.58
11.29
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

53.43
N/A
1.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-100.00
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
62.89
38.30

PAT CAGR (%)

10 Years
5 Years
3 Years

-
43.36
47.45

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

-12.17
-0.55
1.16

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-20.84
-4.40
-0.60

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 35.41 0.00 0 30.42 7.15 325.45% 19.76 0.00 0 7.15 0.00 0
Expenses 34.07 0.24 14,095.83% 27.99 7.66 265.40% 17.73 0.40 4,332.50% 7.66 0.55 1,292.73%
EBITDA 1.34 -0.24 - 2.43 -0.51 - 2.04 -0.40 - -0.51 -0.55 -
EBIDTM 3.78% 0.00% 7.99% -7.17% 10.31% 0.00% -7.17% 0.00%
Other Income 0.11 0.64 -82.81% 0.18 0.02 800.00% 0.18 0.00 0 0.02 0.00 0
Interest 0.02 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.02 0.01 100.00% 0.01 0.00 0 0.01 0.00 0 0.00 0.00 0
PBT 1.42 0.39 264.10% 2.60 -0.50 - 2.21 -0.40 - -0.50 -0.55 -
Tax 0.36 0.00 0 0.03 0.00 0 0.37 0.00 0 0.00 0.00 0
PAT 1.06 0.39 171.79% 2.57 -0.50 - 1.84 -0.40 - -0.50 -0.55 -
PATM 3.00% 0.00% 8.44% -6.99% 9.29% 0.00% -6.99% 0.00%
EPS 0.45 0.17 164.71% 1.08 -0.21 - 0.78 -0.17 - -0.21 -0.23 -

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 92.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.01 7.61 9.65 Net Sales Growth 1,197.06% 0 0 0 0 0 0 -100% -73.59% -21.14% Cost Of Goods Sold 83.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.38 4.14 6.52 Gross Profit 9.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.62 3.47 3.13 GP Margin 9.79% 0 0 0 0 0 0 0 30.85% 45.60% 32.44% Total Expenditure 87.45 1.72 0.74 0.34 0.18 0.15 0.05 0.14 3.04 7.17 9.20 Power & Fuel Cost - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.18 0.24 % Of Sales - 0 0 0 0 0 0 0 5.47% 2.37% 2.49% Employee Cost - 0.69 0.40 0.23 0.09 0.05 0.00 0.03 1.18 0.83 0.68 % Of Sales - 0 0 0 0 0 0 0 58.71% 10.91% 7.05% Manufacturing Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.95 1.09 % Of Sales - 0 0 0 0 0 0 0 6.97% 12.48% 11.30% General & Admin Exp. - 0.62 0.29 0.08 0.07 0.10 0.05 0.05 0.09 0.22 0.37 % Of Sales - 0 0 0 0 0 0 0 4.48% 2.89% 3.83% Selling & Distn. Exp. - 0.32 0.02 0.01 0.01 0.00 0.00 0.05 0.00 0.07 0.25 % Of Sales - 0 0 0 0 0 0 0 0% 0.92% 2.59% Miscellaneous Exp. - 0.08 0.03 0.02 0.01 0.00 0.00 0.00 0.14 0.76 0.25 % Of Sales - 0 0 0 0 0 0 0 6.97% 9.99% 0.41% EBITDA 5.30 -1.72 -0.74 -0.34 -0.18 -0.15 -0.05 -0.14 -1.03 0.44 0.45 EBITDA Margin 5.71% 0 0 0 0 0 0 0 -51.24% 5.78% 4.66% Other Income 0.49 0.64 0.00 0.01 0.00 0.00 0.02 0.01 0.01 0.11 0.02 Interest 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.25 0.17 0.18 Depreciation 0.04 0.01 0.00 0.00 0.01 0.03 0.03 0.03 0.14 0.24 0.24 PBT 5.73 -1.09 -0.74 -0.34 -0.19 -0.18 -0.06 -0.16 -1.41 0.14 0.05 Tax 0.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 Tax Rate 13.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.14% 40.00% PAT 4.97 -1.09 -0.74 -0.34 -0.19 -0.18 -0.06 -0.16 -2.36 0.13 0.03 PAT before Minority Interest 4.97 -1.09 -0.74 -0.34 -0.19 -0.18 -0.06 -0.16 -2.36 0.13 0.03 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.36% 0 0 0 0 0 0 0 -117.41% 1.71% 0.31% PAT Growth 568.87% - - - - - - - - 333.33% EPS 2.10 -0.46 -0.31 -0.14 -0.08 -0.08 -0.03 -0.07 -1.00 0.05 0.01

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 24.65 1.08 -0.73 -0.39 -0.21 -0.03 0.03 0.20 2.55 2.63 Share Capital 23.71 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 Total Reserves 0.95 -5.86 -5.12 -4.78 -4.60 -4.42 -4.36 -4.19 -1.84 -1.76 Non-Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 1.03 2.29 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 1.03 1.18 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 0.57 3.49 1.43 1.12 1.61 1.44 1.44 1.49 2.81 4.24 Trade Payables 0.00 0.00 0.00 0.00 0.19 0.19 0.19 0.21 1.28 2.79 Other Current Liabilities 0.14 1.78 0.05 0.10 0.52 0.60 0.59 0.63 0.88 1.29 Short Term Borrowings 0.44 1.71 1.38 1.03 0.90 0.65 0.65 0.65 0.65 0.10 Short Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 Total Liabilities 25.22 4.57 0.70 0.73 1.40 1.41 1.49 1.70 6.39 9.16 Net Block 0.04 0.00 0.00 0.00 0.01 0.04 0.08 0.11 2.48 2.73 Gross Block 0.05 0.00 0.17 0.17 0.17 0.17 0.17 0.17 2.73 9.02 Accumulated Depreciation 0.01 0.00 0.17 0.17 0.16 0.13 0.09 0.06 0.24 6.29 Non Current Assets 0.07 0.02 0.02 0.02 0.03 0.06 0.14 0.22 2.78 2.94 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.21 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.08 0.08 0.00 Current Assets 25.16 4.55 0.68 0.71 1.37 1.35 1.35 1.48 3.61 6.23 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.32 Sundry Debtors 0.60 0.60 0.60 0.60 1.25 1.25 1.25 1.26 2.95 5.36 Cash & Bank 21.30 2.67 0.00 0.00 0.01 0.01 0.01 0.13 0.09 0.16 Other Current Assets 3.26 0.00 0.00 0.00 0.10 0.08 0.08 0.09 0.35 0.39 Short Term Loans & Adv. 3.26 1.28 0.08 0.10 0.10 0.08 0.08 0.09 0.35 0.39 Net Current Assets 24.59 1.06 -0.75 -0.42 -0.24 -0.09 -0.09 -0.01 0.81 1.99 Total Assets 25.23 4.57 0.70 0.73 1.40 1.41 1.49 1.70 6.39 9.17

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -4.71 -0.21 -0.35 -0.13 -0.25 -0.05 -0.18 -0.12 0.31 0.28 PBT -1.09 -0.74 -0.34 -0.19 -0.18 -0.06 -0.16 -2.36 0.14 0.05 Adjustment 0.01 0.00 0.00 0.01 0.03 0.01 0.03 1.32 0.30 0.41 Changes in Working Capital -3.63 0.53 -0.02 0.04 -0.10 0.00 -0.04 0.94 -0.12 -0.15 Cash after chg. in Working capital -4.71 -0.21 -0.35 -0.13 -0.25 -0.05 -0.18 -0.09 0.32 0.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 -0.01 -0.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.05 0.00 0.00 0.00 0.00 0.06 0.07 1.50 0.01 -0.29 Net Fixed Assets -0.05 0.17 0.00 0.00 0.00 0.00 0.00 2.77 6.29 -0.30 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 -0.17 0.00 0.00 0.00 0.06 0.07 -1.27 -6.28 0.01 Cash from Financing Activity 23.39 2.88 0.36 0.13 0.25 -0.02 0.00 -1.35 -0.32 -0.27 Net Cash Inflow / Outflow 18.63 2.67 0.00 -0.01 0.00 0.00 -0.10 0.04 0.00 -0.28 Opening Cash & Equivalents 2.67 0.00 0.00 0.01 0.01 0.01 0.12 0.08 0.08 0.44 Closing Cash & Equivalent 21.30 2.67 0.00 0.00 0.01 0.01 0.01 0.12 0.08 0.16

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 10.40 -3.34 -1.67 -0.90 -0.47 -0.06 0.07 0.45 5.82 6.00 ROA -7.29% -27.91% -47.15% -17.39% -12.78% -4.11% -10.36% -58.30% 1.67% 0.31% ROE -9.36% 0.00% 0.00% 0.00% 0.00% -2869.33% -144.20% -171.40% 5.02% 1.05% ROCE -7.78% -42.74% -52.60% -27.96% -27.33% -8.82% -19.67% -80.09% 7.49% 5.81% Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.38 1.31 1.08 Receivable days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 383.17 197.08 185.90 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.84 13.83 Payable days 0.00 0.00 0.00 0.00 0.00 0.00 610.38 93.78 118.67 97.56 Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00 0.00 -610.38 289.38 91.25 102.17 Total Debt/Equity 0.02 -1.16 -1.89 -2.61 -4.33 -23.54 20.97 3.58 0.71 0.49 Interest Cover -1084.10 -1471.20 -1088.65 -1698.31 0.00 -50.52 -21.58 -8.33 1.80 1.27

Top Investors:

veeramreddy vijay kumar reddy .

kuniamuthur nanjappan anand

priyam samir shah

somisetty malathi latha

giridhar gupta somisetty

chandraprakash jamnalal kabra

priyam sachdeva

narendra babu veerla

akilandeswari selva murthy

adusumilli sai raghava pratap

Annual Reports:

News Update:

Kabra Drugs gets LoI to establish pharmaceutical manufacturing facility in Chhattisgarh
15th Jun 2026, 09:10 AM

The proposed project envisages an investment of around Rs 200 crore
Read More

Kabra Drugs Ltd.

Pharmaceuticals & Drugs

BSE: 524322 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Kabra Drugs Ltd.

Pharmaceuticals & Drugs

BSE: 524322 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: